2013/11/22 Dr. Ying Luo of GNI Group gives a speech on how to select pre-clinical research labs for Class 1 drug IND filing in China in the 3rd Asia Pharma R&D Outsourcing Congress held in San Diego, California, USA.

2013/11/16 Dr. Ying Luo of GNI Group and Professor Zuojun Xu of Peking Union Hospital presents research and clinical trial data of F647 in the China Medical Society 4th National Interstitial Pulmonary Disease Research Conference held in Guiyang City, Guizhou Province of China. Beijing Continent is also a major sponsor of the conference.

2013/05/30 Dr. Ying Luo presents pirfenidone drug development program in CHI Bio-IT World Asia Conference held in Singapore.

2013/05/21 Dr. Ying Luo presents drug development progress in the 8th International China Pharmaceutical R&D Summit held in Shanghai, China.

2013/03/04 In the 5th China & 3rd Asia Clinical Trials Outsourcing Congress held in Morristown, New Jersey, USA, Dr. Ying Luo presents pirfenidone development program and chaired round-table discussion of China strategy.

© 2007~2018 shanghaigenomics.com. All rights reserved. Shanghai ICP 08017875